FdaApplication

NDA 216655

Back to search

Identifiers

Properties

PropertyValue
applicant_nameXIAMEN LP PHARMACUETICAL CO LTD
application_typeNDA
approval_date2024-07-22

Products (3)

ProductActive ingredientStrengthDosage form
OPIPZAARIPIPRAZOLE5MGFILM;ORAL
OPIPZAARIPIPRAZOLE10MGFILM;ORAL
OPIPZAARIPIPRAZOLE2MGFILM;ORAL

3 products